A recent article reported on the results of a trial of the cholesterol-lowering drug Zytorin, which is a combination of Zocor and Zeita - made by Merck and Schering-Plough. Zocor and Zeita lower cholesterol by different mechanisms, so the idea was that combining them into a single drug (Vytorin) would dramatically lower cholesterol and, they assumed, reduce heart disease. They got the first part right. Vytorin did indeed lead to dramatic reductions in cholesterol levels in those who ...
Read More »